 | • レポートコード：MRC2Q12-10216 • 出版社/出版日：QYResearch / 2022年12月 • レポート形態：英文、PDF、117ページ • 納品方法：Eメール（納期：3営業日） • 産業分類：電子＆半導体 |
| Single User | ￥725,200 (USD4,900) | ▷ お問い合わせ |
| Enterprise License | ￥1,450,400 (USD9,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 新型コロナウイルス感染症とロシア・ウクライナ戦争の影響により、臓器チップのグローバル市場は 2022にxxxドルと推定され、2028年までにxxxドルの規模に達し、2022年から2028年の予測期間中にxxx%のCAGRで成長すると予測されています。 臓器チップのアメリカ市場は、2023年から2028年の予測期間中にxxx%のCAGRで、2022年xxxドルから2028年xxxドルに達すると推定されています。 臓器チップの中国市場は、2023年から2028年の予測期間中にxxx%のCAGRで、2022年xxxドルから2028年xxxドルに達すると推定されています。 臓器チップのヨーロッパ市場は、2023年から2028年の予測期間中にxxx%のCAGRで、2022年xxxドルから2028年xxxドルに達すると推定されています。 生産面において、本レポートは2017年から2022年までの臓器チップの生産、成長率、メーカー別市場シェア、地域別市場シェア、および2028年までの予測を調査しています。販売面において、本レポートは2017年から2022年までの地域別、企業別、タイプ別、アプリケーション別の臓器チップの売上および2028年までの予測に焦点を当てています。 臓器チップのグローバル主要企業には、Emulate、Mimetas、TissUse、Tara Biosystems、CN Bio Innovations、Hesperos、Draper Laboratory、Nortis、Micronit Microtechnologies B.V.、Kirkstall、Cherry Biotech SAS、Else Kooi Laboratory、Altis Biosystems、Bi/ond、Netri、Beijing Daxiang Biotechなどがあります。2021年、世界のトップ5プレイヤーは売上ベースで約xxx％の市場シェアを占めています。 臓器チップ市場は、タイプとアプリケーションによって区分されます。世界の臓器チップ市場のプレーヤー、利害関係者、およびその他の参加者は、当レポートを有益なリソースとして使用することで優位に立つことができます。セグメント分析は、2017年～2028年期間のタイプ別およびアプリケーション別の販売量、売上、予測に焦点を当てています。 【タイプ別セグメント】 脳オンチップ、肝臓オンチップ、腎臓オンチップ、肺オンチップ、心臓オンチップ、腸オンチップ、血管-オンチップ、その他の臓器 【アプリケーション別セグメント】 製薬/バイオ企業、学術/研究機関、化粧品産業、その他 【掲載地域】 北米：アメリカ、カナダ ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア アジア太平洋：日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア 中南米：メキシコ、ブラジル、アルゼンチン 中東・アフリカ：トルコ、サウジアラビア、UAE 【目次（一部）】 ・調査の範囲 - 臓器チップ製品概要 - タイプ別市場（脳オンチップ、肝臓オンチップ、腎臓オンチップ、肺オンチップ、心臓オンチップ、腸オンチップ、血管-オンチップ、その他の臓器） - アプリケーション別市場（製薬/バイオ企業、学術/研究機関、化粧品産業、その他） - 調査の目的 ・エグゼクティブサマリー - 世界の臓器チップ販売量予測2017-2028 - 世界の臓器チップ売上予測2017-2028 - 臓器チップの地域別販売量 - 臓器チップの地域別売上 - 北米市場 - ヨーロッパ市場 - アジア太平洋市場 - 中南米市場 - 中東・アフリカ市場 ・メーカーの競争状況 - 主要メーカー別臓器チップ販売量 - 主要メーカー別臓器チップ売上 - 主要メーカー別臓器チップ価格 - 競争状況の分析 - 企業M&A動向 ・タイプ別市場規模（脳オンチップ、肝臓オンチップ、腎臓オンチップ、肺オンチップ、心臓オンチップ、腸オンチップ、血管-オンチップ、その他の臓器） - 臓器チップのタイプ別販売量 - 臓器チップのタイプ別売上 - 臓器チップのタイプ別価格 ・アプリケーション別市場規模（製薬/バイオ企業、学術/研究機関、化粧品産業、その他） - 臓器チップのアプリケーション別販売量 - 臓器チップのアプリケーション別売上 - 臓器チップのアプリケーション別価格 ・北米市場 - 北米の臓器チップ市場規模（タイプ別、アプリケーション別） - 主要国別の臓器チップ市場規模（アメリカ、カナダ） ・ヨーロッパ市場 - ヨーロッパの臓器チップ市場規模（タイプ別、アプリケーション別） - 主要国別の臓器チップ市場規模（ドイツ、フランス、イギリス、イタリア、ロシア） ・アジア太平洋市場 - アジア太平洋の臓器チップ市場規模（タイプ別、アプリケーション別） - 主要国別の臓器チップ市場規模（日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア） ・中南米市場 - 中南米の臓器チップ市場規模（タイプ別、アプリケーション別） - 主要国別の臓器チップ市場規模（メキシコ、ブラジル、アルゼンチン） ・中東・アフリカ市場 - 中東・アフリカの臓器チップ市場規模（タイプ別、アプリケーション別） - 主要国別の臓器チップ市場規模（トルコ、サウジアラビア） ・企業情報 Emulate、Mimetas、TissUse、Tara Biosystems、CN Bio Innovations、Hesperos、Draper Laboratory、Nortis、Micronit Microtechnologies B.V.、Kirkstall、Cherry Biotech SAS、Else Kooi Laboratory、Altis Biosystems、Bi/ond、Netri、Beijing Daxiang Biotech ・産業チェーン及び販売チャネル分析 - 臓器チップの産業チェーン分析 - 臓器チップの原材料 - 臓器チップの生産プロセス - 臓器チップの販売及びマーケティング - 臓器チップの主要顧客 ・マーケットドライバー、機会、課題、リスク要因分析 - 臓器チップの産業動向 - 臓器チップのマーケットドライバー - 臓器チップの課題 - 臓器チップの阻害要因 ・主な調査結果 |
An Organ-On-Chip (OOC) is a multi-channel 3-D microfluidic cell culture chip that simulates the activities, mechanics and physiological response of entire organs and organ systems, a type of artificial organ. It constitutes the subject matter of significant biomedical engineering research, more precisely in bio-MEMS. The convergence of labs-on-chips (LOCs) and cell biology has permitted the study of human physiology in an organ-specific context, introducing a novel model of in vitro multicellular human organisms. One day, they will perhaps abolish the need for animals in drug development and toxin testing. Organ-On-Chip technology not only incorporates multiple cell types but also involves engineering aspects, such as the guided spatial confinement of cells or the incorporation of sensors and microfluidic channels.
The primary focus of Organ-On-Chip technology is the re-creation of three key aspects of human physiology: the multicellular vascular or epithelial interfaces of organs (for example, blood vessel networks, lung and gut), which function as barriers in tissues; the tissue-level organization of parenchymal cells (for example, liver, heart, skeletal muscle and tumours), which are responsible for the key functional properties of an organ; and the systematic interaction of multiple organs (for example, drug absorption, distribution, metabolism and elimination involving the gut, circulation, liver and kidney).
In addition, the Blood-Brain Barrier is definitely more complex than a simple wall, controlling the passage of most solute that enters or leaves the brain. To address how this molecular sieve affects neural activity, some researchers have simulated the interaction between blood vessels and brain tissue on a series of interconnected “organ chips” when connected through this Blood-Brain Barrier (BBB) model. Endothelial cells, pericytes, astrocytes and neurons alter their gene expression. These technologies will achieve even more rapid development and application.
Report Overview
Due to the COVID-19 pandemic and Russia-Ukraine War Influence, the global market for Organ On Chip estimated at US$ 88 million in the year 2022, is projected to reach a revised size of US$ 487 million by 2028, growing at a CAGR of 33.0% during the forecast period 2022-2028.
Global organ on chip key players include Emulate, TissUse, Hesperos, CN Bio Innovations, Tara Biosystems, etc. Global top 5 manufacturers hold a share about 55%.
North America is the largest market, with a share about 40%, followed by Europe and Asia-Pacific, both have a share about 50 percent.
In terms of product, liver-on-a-chip is the largest segment, with a share about 25%. And in terms of application, the largest application is pharmaceutical & biotechnology companies, followed by academic & research institutes.
Report Scope
This latest report researches the industry structure, revenue and gross margin. Major players’ headquarters, market shares, industry ranking and profiles are presented. The primary and secondary research is done in order to access up-to-date government regulations, market information and industry data. Data were collected from the Organ On Chip companies, distributors, end users, industry associations, governments’ industry bureaus, industry publications, industry experts, third party database, and our in-house databases.
This report also includes a discussion of the major players across each regional Organ On Chip market. Further, it explains the major drivers and regional dynamics of the global Organ On Chip market and current trends within the industry.
Key Companies Covered
In this section of the report, the researchers have done a comprehensive analysis of the prominent players operating and the strategies they are focusing on to combat the intense competition. Company profiles and market share analysis of the prominent players are also provided in this section. Additionally, the specialists have done an all-encompassing analysis of each player. They have also provided reliable revenue, market share and rank data of the companies for the period 2017-2022. With the assistance of this report, key players, stakeholders, and other participants will be able to stay abreast of the recent and upcoming developments in the business, further enabling them to make efficient choices. Mentioned below are the prime players taken into account in this research report:
Emulate
Mimetas
TissUse
Tara Biosystems
CN Bio Innovations
Hesperos
Draper Laboratory
Nortis
Micronit Microtechnologies B.V.
Kirkstall
Cherry Biotech SAS
Else Kooi Laboratory
Altis Biosystems
Bi/ond
Netri
Beijing Daxiang Biotech
Market Segments
This report has explored the key segments: by Type and by End User. The lucrativeness and growth potential have been looked into by the industry experts in this report. This report also provides revenue forecast data by type and by end user segments based on value for the period 2017-2028.
Organ On Chip Segment by Type
Brain-on-a-chip
Liver-on-a-chip
Kidney-on-a-chip
Lung-on-a-chip
Heart-on-a-chip
Intestine-on-a-chip
Vessel-on-a-chip
Other Organs
Organ On Chip Segment by End User
Pharmaceutical & Biotechnology Companies
Academic & Research Institutes
Cosmetics Industry
Others
Key Regions & Countries
This section of the report provides key insights regarding various regions and the key players operating in each region. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of the particular region/country. The readers will also get their hands on the value data of each region and country for the period 2017-2028.
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
COVID-19 and Russia-Ukraine War Influence Analysis
The readers in the section will understand how the Organ On Chip market scenario changed across the globe during the pandemic, post-pandemic and Russia-Ukraine War. The study is done keeping in view the changes in aspects such as demand, consumption, transportation, consumer behavior, supply chain management, export and import, and production. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.
Report Includes:
This report presents an overview of global market for Organ On Chip market size. Analyses of the global market trends, with historic market revenue data for 2017 – 2021, estimates for 2022, and projections of CAGR through 2028.
This report researches the key producers of Organ On Chip, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Organ On Chip, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Organ On Chip revenue, market share and industry ranking of main companies, data from 2017 to 2022. Identification of the major stakeholders in the global Organ On Chip market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by type and by application, revenue, and growth rate, from 2017 to 2028. Evaluation and forecast the market size for Organ On Chip revenue, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including Emulate, Mimetas, TissUse, Tara Biosystems, CN Bio Innovations, Hesperos, Draper Laboratory, Nortis and Micronit Microtechnologies B.V., etc.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Revenue of Organ On Chip in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Organ On Chip companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments according to product types, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments according to application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America by type, by end user and by country, revenue for each segment.
Chapter 7: Europe by type, by end user and by country, revenue for each segment.
Chapter 8: Asia Pacific by type, by end user and by country/region, revenue for each segment.
Chapter 9: Latin America by type, by end user and by country, revenue for each segment.
Chapter 10: Middle East and Africa by type, by end user and by country, revenue for each segment.
Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Organ On Chip revenue, gross margin, and recent development, etc.
Chapter 12: Analyst’s Viewpoints/Conclusions
1 Report Business Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Organ On Chip Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Brain-on-a-chip
1.2.3 Liver-on-a-chip
1.2.4 Kidney-on-a-chip
1.2.5 Lung-on-a-chip
1.2.6 Heart-on-a-chip
1.2.7 Intestine-on-a-chip
1.2.8 Vessel-on-a-chip
1.2.9 Other Organs
1.3 Market by End User
1.3.1 Global Organ On Chip Market Size Growth Rate by End User, 2017 VS 2021 VS 2028
1.3.2 Pharmaceutical & Biotechnology Companies
1.3.3 Academic & Research Institutes
1.3.4 Cosmetics Industry
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Organ On Chip Market Perspective (2017-2028)
2.2 Organ On Chip Growth Trends by Region
2.2.1 Organ On Chip Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Organ On Chip Historic Market Size by Region (2017-2022)
2.2.3 Organ On Chip Forecasted Market Size by Region (2023-2028)
2.3 Organ On Chip Market Dynamics
2.3.1 Organ On Chip Industry Trends
2.3.2 Organ On Chip Market Drivers
2.3.3 Organ On Chip Market Challenges
2.3.4 Organ On Chip Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Organ On Chip Players by Revenue
3.1.1 Global Top Organ On Chip Players by Revenue (2017-2022)
3.1.2 Global Organ On Chip Revenue Market Share by Players (2017-2022)
3.2 Global Organ On Chip Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Organ On Chip Revenue
3.4 Global Organ On Chip Market Concentration Ratio
3.4.1 Global Organ On Chip Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Organ On Chip Revenue in 2021
3.5 Organ On Chip Key Players Head office and Area Served
3.6 Key Players Organ On Chip Product Solution and Service
3.7 Date of Enter into Organ On Chip Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Organ On Chip Breakdown Data by Type
4.1 Global Organ On Chip Historic Market Size by Type (2017-2022)
4.2 Global Organ On Chip Forecasted Market Size by Type (2023-2028)
5 Organ On Chip Breakdown Data by End User
5.1 Global Organ On Chip Historic Market Size by End User (2017-2022)
5.2 Global Organ On Chip Forecasted Market Size by End User (2023-2028)
6 North America
6.1 North America Organ On Chip Market Size (2017-2028)
6.2 North America Organ On Chip Market Size by Type
6.2.1 North America Organ On Chip Market Size by Type (2017-2022)
6.2.2 North America Organ On Chip Market Size by Type (2023-2028)
6.2.3 North America Organ On Chip Market Share by Type (2017-2028)
6.3 North America Organ On Chip Market Size by End User
6.3.1 North America Organ On Chip Market Size by End User (2017-2022)
6.3.2 North America Organ On Chip Market Size by End User (2023-2028)
6.3.3 North America Organ On Chip Market Share by End User (2017-2028)
6.4 North America Organ On Chip Market Size by Country
6.4.1 North America Organ On Chip Market Size by Country (2017-2022)
6.4.2 North America Organ On Chip Market Size by Country (2023-2028)
6.4.3 U.S.
6.4.4 Canada
7 Europe
7.1 Europe Organ On Chip Market Size (2017-2028)
7.2 Europe Organ On Chip Market Size by Type
7.2.1 Europe Organ On Chip Market Size by Type (2017-2022)
7.2.2 Europe Organ On Chip Market Size by Type (2023-2028)
7.2.3 Europe Organ On Chip Market Share by Type (2017-2028)
7.3 Europe Organ On Chip Market Size by End User
7.3.1 Europe Organ On Chip Market Size by End User (2017-2022)
7.3.2 Europe Organ On Chip Market Size by End User (2023-2028)
7.3.3 Europe Organ On Chip Market Share by End User (2017-2028)
7.4 Europe Organ On Chip Market Size by Country
7.4.1 Europe Organ On Chip Market Size by Country (2017-2022)
7.4.2 Europe Organ On Chip Market Size by Country (2023-2028)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Organ On Chip Market Size (2017-2028)
8.2 Asia-Pacific Organ On Chip Market Size by Type
8.2.1 Asia-Pacific Organ On Chip Market Size by Type (2017-2022)
8.2.2 Asia-Pacific Organ On Chip Market Size by Type (2023-2028)
8.2.3 Asia-Pacific Organ On Chip Market Share by Type (2017-2028)
8.3 Asia-Pacific Organ On Chip Market Size by End User
8.3.1 Asia-Pacific Organ On Chip Market Size by End User (2017-2022)
8.3.2 Asia-Pacific Organ On Chip Market Size by End User (2023-2028)
8.3.3 Asia-Pacific Organ On Chip Market Share by End User (2017-2028)
8.4 Asia-Pacific Organ On Chip Market Size by Region
8.4.1 Asia-Pacific Organ On Chip Market Size by Region (2017-2022)
8.4.2 Asia-Pacific Organ On Chip Market Size by Region (2023-2028)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Organ On Chip Market Size (2017-2028)
9.2 Latin America Organ On Chip Market Size by Type
9.2.1 Latin America Organ On Chip Market Size by Type (2017-2022)
9.2.2 Latin America Organ On Chip Market Size by Type (2023-2028)
9.2.3 Latin America Organ On Chip Market Share by Type (2017-2028)
9.3 Latin America Organ On Chip Market Size by End User
9.3.1 Latin America Organ On Chip Market Size by End User (2017-2022)
9.3.2 Latin America Organ On Chip Market Size by End User (2023-2028)
9.3.3 Latin America Organ On Chip Market Share by End User (2017-2028)
9.4 Latin America Organ On Chip Market Size by Country
9.4.1 Latin America Organ On Chip Market Size by Country (2017-2022)
9.4.2 Latin America Organ On Chip Market Size by Country (2023-2028)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Organ On Chip Market Size (2017-2028)
10.2 Middle East & Africa Organ On Chip Market Size by Type
10.2.1 Middle East & Africa Organ On Chip Market Size by Type (2017-2022)
10.2.2 Middle East & Africa Organ On Chip Market Size by Type (2023-2028)
10.2.3 Middle East & Africa Organ On Chip Market Share by Type (2017-2028)
10.3 Middle East & Africa Organ On Chip Market Size by End User
10.3.1 Middle East & Africa Organ On Chip Market Size by End User (2017-2022)
10.3.2 Middle East & Africa Organ On Chip Market Size by End User (2023-2028)
10.3.3 Middle East & Africa Organ On Chip Market Share by End User (2017-2028)
10.4 Middle East & Africa Organ On Chip Market Size by Country
10.4.1 Middle East & Africa Organ On Chip Market Size by Country (2017-2022)
10.4.2 Middle East & Africa Organ On Chip Market Size by Country (2023-2028)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Emulate
11.1.1 Emulate Company Details
11.1.2 Emulate Business Overview
11.1.3 Emulate Organ On Chip Introduction
11.1.4 Emulate Revenue in Organ On Chip Business (2017-2022)
11.1.5 Emulate Recent Developments
11.2 Mimetas
11.2.1 Mimetas Company Details
11.2.2 Mimetas Business Overview
11.2.3 Mimetas Organ On Chip Introduction
11.2.4 Mimetas Revenue in Organ On Chip Business (2017-2022)
11.2.5 Mimetas Recent Developments
11.3 TissUse
11.3.1 TissUse Company Details
11.3.2 TissUse Business Overview
11.3.3 TissUse Organ On Chip Introduction
11.3.4 TissUse Revenue in Organ On Chip Business (2017-2022)
11.3.5 TissUse Recent Developments
11.4 Tara Biosystems
11.4.1 Tara Biosystems Company Details
11.4.2 Tara Biosystems Business Overview
11.4.3 Tara Biosystems Organ On Chip Introduction
11.4.4 Tara Biosystems Revenue in Organ On Chip Business (2017-2022)
11.4.5 Tara Biosystems Recent Developments
11.5 CN Bio Innovations
11.5.1 CN Bio Innovations Company Details
11.5.2 CN Bio Innovations Business Overview
11.5.3 CN Bio Innovations Organ On Chip Introduction
11.5.4 CN Bio Innovations Revenue in Organ On Chip Business (2017-2022)
11.5.5 CN Bio Innovations Recent Developments
11.6 Hesperos
11.6.1 Hesperos Company Details
11.6.2 Hesperos Business Overview
11.6.3 Hesperos Organ On Chip Introduction
11.6.4 Hesperos Revenue in Organ On Chip Business (2017-2022)
11.6.5 Hesperos Recent Developments
11.7 Draper Laboratory
11.7.1 Draper Laboratory Company Details
11.7.2 Draper Laboratory Business Overview
11.7.3 Draper Laboratory Organ On Chip Introduction
11.7.4 Draper Laboratory Revenue in Organ On Chip Business (2017-2022)
11.7.5 Draper Laboratory Recent Developments
11.8 Nortis
11.8.1 Nortis Company Details
11.8.2 Nortis Business Overview
11.8.3 Nortis Organ On Chip Introduction
11.8.4 Nortis Revenue in Organ On Chip Business (2017-2022)
11.8.5 Nortis Recent Developments
11.9 Micronit Microtechnologies B.V.
11.9.1 Micronit Microtechnologies B.V. Company Details
11.9.2 Micronit Microtechnologies B.V. Business Overview
11.9.3 Micronit Microtechnologies B.V. Organ On Chip Introduction
11.9.4 Micronit Microtechnologies B.V. Revenue in Organ On Chip Business (2017-2022)
11.9.5 Micronit Microtechnologies B.V. Recent Developments
11.10 Kirkstall
11.10.1 Kirkstall Company Details
11.10.2 Kirkstall Business Overview
11.10.3 Kirkstall Organ On Chip Introduction
11.10.4 Kirkstall Revenue in Organ On Chip Business (2017-2022)
11.10.5 Kirkstall Recent Developments
11.11 Cherry Biotech SAS
11.11.1 Cherry Biotech SAS Company Details
11.11.2 Cherry Biotech SAS Business Overview
11.11.3 Cherry Biotech SAS Organ On Chip Introduction
11.11.4 Cherry Biotech SAS Revenue in Organ On Chip Business (2017-2022)
11.11.5 Cherry Biotech SAS Recent Developments
11.12 Else Kooi Laboratory
11.12.1 Else Kooi Laboratory Company Details
11.12.2 Else Kooi Laboratory Business Overview
11.12.3 Else Kooi Laboratory Organ On Chip Introduction
11.12.4 Else Kooi Laboratory Revenue in Organ On Chip Business (2017-2022)
11.12.5 Else Kooi Laboratory Recent Developments
11.13 Altis Biosystems
11.13.1 Altis Biosystems Company Details
11.13.2 Altis Biosystems Business Overview
11.13.3 Altis Biosystems Organ On Chip Introduction
11.13.4 Altis Biosystems Revenue in Organ On Chip Business (2017-2022)
11.13.5 Altis Biosystems Recent Developments
11.14 Bi/ond
11.14.1 Bi/ond Company Details
11.14.2 Bi/ond Business Overview
11.14.3 Bi/ond Organ On Chip Introduction
11.14.4 Bi/ond Revenue in Organ On Chip Business (2017-2022)
11.14.5 Bi/ond Recent Developments
11.15 Netri
11.15.1 Netri Company Details
11.15.2 Netri Business Overview
11.15.3 Netri Organ On Chip Introduction
11.15.4 Netri Revenue in Organ On Chip Business (2017-2022)
11.15.5 Netri Recent Developments
11.16 Beijing Daxiang Biotech
11.16.1 Beijing Daxiang Biotech Company Details
11.16.2 Beijing Daxiang Biotech Business Overview
11.16.3 Beijing Daxiang Biotech Organ On Chip Introduction
11.16.4 Beijing Daxiang Biotech Revenue in Organ On Chip Business (2017-2022)
11.16.5 Beijing Daxiang Biotech Recent Developments
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Author Details
13.3 Disclaimer